Cargando…
Corrigendum: Novel molecular therapeutics targeting signaling pathway to control hepatitis B viral infection
Autores principales: | Yan, Yan, Qiu, Yuanwang, Davgadorj, Chantsalmaa, Zheng, Chunfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402635/ https://www.ncbi.nlm.nih.gov/pubmed/37545856 http://dx.doi.org/10.3389/fcimb.2023.1253110 |
Ejemplares similares
-
Novel Molecular Therapeutics Targeting Signaling Pathway to Control Hepatitis B Viral Infection
por: Yan, Yan, et al.
Publicado: (2022) -
Immunogenicity of a third dose of inactivated COVID-19 vaccine in people living with HIV-1, HBV, and tuberculosis during the Omicron variant epidemic: A cross-sectional study
por: Yan, Yan, et al.
Publicado: (2022) -
Corrigendum: CVB3-Mediated Mitophagy Plays an Important Role in Viral Replication via Abrogation of Interferon Pathways
por: Oh, Soo-Jin, et al.
Publicado: (2021) -
Metabolomics in viral hepatitis: advances and review
por: Yang, Jiajia, et al.
Publicado: (2023) -
Corrigendum: Hepatitis B Virus Infection Alters Gut Microbiota Composition in Mice
por: Zhu, Qingfeng, et al.
Publicado: (2020)